Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook Life Science Investing
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 Life Science Investing
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Life Science Investing
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results Life Science Investing
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. 4Q 2025 Life Science Investing
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete Life Science Investing
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026 Life Science Investing
Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy Life Science Investing
Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category Life Science Investing
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates Pharmaceutical Investing
